Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show
GLEN ALLEN, Va., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
Addiction
Odyssey Behavioral Healthcare 2024 Outcomes Report Shows Record Symptom Reductions Across Psychiatric, Eating Disorder Networks
New data notably exceed national benchmarks for recovery and clinical improvement. FRANKLIN, TN / ACCESS Newswire / October 16, 2025...
81% of Americans Say Mental Health Support Can’t Wait – They Expect It Within Hours, New CallTrackingMetrics Report Finds
Nearly half need help immediately; Millennials embrace tech-based tools while Baby Boomers resist MILLERSVILLE, Md., Oct. 15, 2025 /PRNewswire/ --...
STAT Wins 2025 Loeb Award for Explanatory Reporting
BOSTON, Oct. 10, 2025 /PRNewswire/ -- STAT addiction reporter Lev Facher won a 2025 Loeb Award, the highest honor in business...
Anonymous Health Appoints Industry Leader Bob Poznanovich to Spearhead Inaugural Advisory Council
SAN FRANCISCO, Oct. 10, 2025 /PRNewswire/ -- Anonymous Health, the most comprehensive AI suite for behavioral health, today announced the...
30+ Provider Groups Adopt Nabla’s Ambient AI Through the athenahealth Marketplace in First Year
This integration through the athenahealth Marketplace, is helping Nabla enable clinicians to complete documentation 24% faster and eliminate after-hours charting,...
Hazelden Betty Ford Recognized by Newsweek’s “America’s Best Addiction Treatment Centers 2025”
Addiction treatment and mental health system achieves top rankings in Minnesota, California and OregonCenter City, Minnesota; Rancho Mirage, California and...
Arcadia Medicine Announces FDA Clearance of IND Application for a Patented Form of MDMA
SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Arcadia Medicine (‘Arcadia’), a company developing safer empathogens to treat mental health...
Psilera Inc. Secures National Institutes of Health Grant for AUD Research
Small Business Innovation Research Grant will advance a novel neuroplastogen towards IND as potential treatment for Alcohol Use Disorder (AUD)....
SleepSpace Awarded NIH Grant to Transform Smartphones Into Digital Therapeutics for Insomnia, Cognition and Mental Health
SleepSpace Secures NIH Support to Pioneer the First Smartphone-Based Digital Therapeutic for Insomnia and Cognitive Health NEW YORK CITY, NEW...
New Study Confirms Recovery Connect App Improves Outcomes in Opioid Treatment
Community Medical Services Clinics saw up to 21% higher retention and patients linked to counselors through the app were 55%...
Transformed by His Promises Offers a 12-Week Journey to Emotional and Behavioral Freedom
Released in time for World Mental Health Day, "Transformed by His Promises" equips readers with clinically informed strategies and structured...
Spring Health Convenes AI in Mental Health Safety & Ethics Council to Set Industry Standards for Responsible AI
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Today, a coalition of leaders from academia, healthcare, technology, and employee benefits announced the...
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction
Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA's advancing programs including Ketamir-2 and MIRA-55 MIAMI,...
Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market
Revolutionary platform aims to make life-saving overdose reversal therapies more affordable, accessible, and effective worldwideVANCOUVER, British Columbia, Sept. 30, 2025...
Clearmind Medicine’s Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies
Vancouver, Canada, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Shoreline Recovery Center Marks International Overdose Awareness Day, Honoring Families, First Responders, and Recovery Advocates
The Encinitas facility shines a light on families, first responders, and individuals in recovery while calling for education, compassion, and...
NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- NeuraClick, Inc., an innovative, preclinical-stage biopharmaceutical company reimagining patient health through the...
Unlikely Collaborators Presents: Hacking Our Minds for Better Health
A Four-Part Spark Salon Series with Dr. Jud Brewer SANTA MONICA, Calif., Sept. 22, 2025 /PRNewswire/ -- Unlikely Collaborators will...
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog
Study demonstrated Ketamir-2 was safe and well tolerated at all dose levels, with a favorable safety and tolerability profile, with...